Viewing Study NCT00960960


Ignite Creation Date: 2025-12-25 @ 2:05 AM
Ignite Modification Date: 2025-12-26 @ 12:43 AM
Study NCT ID: NCT00960960
Status: COMPLETED
Last Update Posted: 2016-12-15
First Post: 2009-08-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of PI3-Kinase Inhibitor GDC-0941 in Combination With Paclitaxel, With and Without Bevacizumab or Trastuzumab, and With Letrozole, in Participants With Locally Recurrent or Metastatic Breast Cancer
Sponsor:
Organization: